Safety Risks Associated with Certain Bulk Drug Substances Nominated for Use in Compounding

Category 2 of the Bulk Substances Nominated Under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act

Source: FDA Center for Drug Evaluation and Research - What's New - June 15, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news